Early Esophageal Cancer pCR Rates Are Raised by Neoadjuvant PD-1 Blockade.

Published Date: 26 Jan 2024

Will this help with general survival and event-free play, though?

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The majority of cancer medications that receive expedited approval end up failing confirmatory trials.

2.

Eliminating the SRC-3 gene in immune cells causes an efficient, long-lasting anti-cancer response.

3.

novel technique for early myelodysplastic syndrome relapse detection in blood cancer patients.

4.

Certain Oral Bacteria May Be a Risk Factor for Head and Neck Cancer

5.

Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLC


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot